Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings

1Mallah, S.I., Ghorab, O.K., Al-Salmi, S., et al. COVID-19: breaking down a global health crisis. Annals of clinical microbiology and antimicrobials, 2021;20(1), pp.1-36. Mallah S.I. Ghorab O.K. Al-Salmi S. et al COVID-19: breaking down a global health crisis Annals of clinical microbiology and antimicrobials 2021201 pp 1 3610.1186/s12941-021-00438-7812996434006330Search in Google Scholar

2Huang, C, Yeming W, Xingwang L, et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” The Lancet 395, no. 10223, (2020): 497-506. Huang C Yeming W Xingwang L et al “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China ” The Lancet 395 no. 10223 2020 497 50610.1016/S0140-6736(20)30183-5715929931986264Search in Google Scholar

3Horby, P., Lim, W.S. and Landray, M.J. et al. Dexamethasone in hospitalized patients with Covid-19. The New England journal of medicine, 2021; 8(384), pp.693-704. Horby P. Lim W.S. and Landray M.J. et al Dexamethasone in hospitalized patients with Covid-19 The New England journal of medicine 2021 8384 pp 693 70410.1056/NEJMoa2021436738359532678530Search in Google Scholar

4Dequin, PF., Heming, N., Meziani, F., et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. Jama, 2020; 324(13), pp.1298-1306. Dequin PF. Heming N. Meziani F. et al Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial Jama 2020 32413 pp 1298 130610.1001/jama.2020.16761748943232876689Search in Google Scholar

5Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. Jama. 2020;324(13):1317-29. Angus DC Derde L Al-Beidh F et al Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial Jama 2020324131317 2910.1001/jama.2020.17022748941832876697Search in Google Scholar

6Jeronimo CM, Farias ME, Val FF, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019: a randomized, double-blind, phase IIb, placebo-controlled trial. Clinical Infectious Diseases. 2021;72(9): e373-81. Jeronimo CM Farias ME Val FF et al Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019: a randomized, double-blind, phase IIb, placebo-controlled trial Clinical Infectious Diseases 2021729 e373 8110.1093/cid/ciaa1177745432032785710Search in Google Scholar

7Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical care medicine. 1985;13(10):818-29. Knaus WA Draper EA Wagner DP Zimmerman JE APACHE II: a severity of disease classification system Critical care medicine 19851310818 2910.1097/00003246-198510000-00009Search in Google Scholar

8Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. Journal of general internal medicine. 2013;28(11):1504-10. Chapman EN Kaatz A Carnes M Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities Journal of general internal medicine 201328111504 1010.1007/s11606-013-2441-1379736023576243Search in Google Scholar

9Obata R, Maeda T, Rizk D, Kuno T. Increased secondary infection in COVID-19 patients treated with steroids in New York City. Jpn J Infect Dis. 2021 Jul 21;74(4):307-15. Obata R Maeda T Rizk D Kuno T Increased secondary infection in COVID-19 patients treated with steroids in New York City Jpn J Infect Dis 2021 Jul 21744307 1510.7883/yoken.JJID.2020.88433390434Search in Google Scholar

10Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia. 2020;34(6):1503-11. Li H Chen C Hu F et al Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis Leukemia 20203461503 1110.1038/s41375-020-0848-3719965032372026Search in Google Scholar

11Xu K, Chen Y, Yuan J. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020. [EPUB ahead of the print] Xu K Chen Y Yuan J Factors associated with prolonged viral RNA shedding in patients with COVID-19 Clin Infect Dis 2020 [EPUB ahead of the print]Search in Google Scholar

12Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 2021;27(1):83-8. Garcia-Vidal C Sanjuan G Moreno-García E et al Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study Clinical Microbiology and Infection 202127183 810.1016/j.cmi.2020.07.041783676232745596Search in Google Scholar

13Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(1530-1539):10-16. Ng JH Hirsch JS Wanchoo R et al Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 Kidney Int 2020981530-153910 1610.1016/j.kint.2020.07.030742872032810523Search in Google Scholar

14Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. Journal of allergy and clinical immunology. 1985;76(2):234-42. Bowyer SL LaMothe MP Hollister JR Steroid myopathy: incidence and detection in a population with asthma Journal of allergy and clinical immunology 1985762234 4210.1016/0091-6749(85)90708-04019954Search in Google Scholar

15Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ open. 2014;4(5):e004587. Narum S Westergren T Klemp M Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis BMJ open 201445e00458710.1136/bmjopen-2013-004587402545024833682Search in Google Scholar

16Goforth P, Gudas CJ. Effects of steroids on wound healing: a review of the literature. The Journal of foot surgery. 1980;19(1):22-8. Goforth P Gudas CJ Effects of steroids on wound healing: a review of the literature The Journal of foot surgery 198019122 8Search in Google Scholar

17Ravindran NP, Halder A, Harshe D, Harshe S, Harshe G. A qualitative analysis of literature reporting and linking psychosis to COVID-19 infection. Asian journal of psychiatry. 2022:103099. Ravindran NP Halder A Harshe D Harshe S Harshe G A qualitative analysis of literature reporting and linking psychosis to COVID-19 infection Asian journal of psychiatry 202210309910.1016/j.ajp.2022.103099898348335461146Search in Google Scholar

18Nadeem R, Aijazi I, Elhoufi A, et al. Clinical Profile of Mortality and Treatment Profile of Survival in Patients with COVID-19 Pneumonia Admitted to Dubai Hospital. Dubai Medical Journal. 2021;4(2):170-6. Nadeem R Aijazi I Elhoufi A et al Clinical Profile of Mortality and Treatment Profile of Survival in Patients with COVID-19 Pneumonia Admitted to Dubai Hospital Dubai Medical Journal 202142170 610.1159/000516591Search in Google Scholar

19Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clinical Infectious Diseases. 2000;31(5):1170-4. Mylotte JM Tayara A Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort Clinical Infectious Diseases 20003151170 410.1086/31742111073748Search in Google Scholar

20Lino K, Guimarães GM, Alves LS, et al. Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality. Brazilian Journal of Infectious Diseases. 2021;25. Lino K Guimarães GM Alves LS et al Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality Brazilian Journal of Infectious Diseases 20212510.1016/j.bjid.2021.101569795926633736948Search in Google Scholar

21Ali A, Noman M, Guo Y, et al. Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality. Scientific reports. 2021 Mar 16;11(1):1-3. Ali A Noman M Guo Y et al Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality Scientific reports 2021 Mar 161111 310.1038/s41598-021-85426-9797104933727641Search in Google Scholar

22Ahmed Y, Cao A, Thal A, et al. Tracheotomy outcomes in 64 ventilated COVID‐19 patients at a high‐volume center in Bronx, NY. The Laryngoscope. 2021;131(6):E1797-804. Ahmed Y Cao A Thal A et al Tracheotomy outcomes in 64 ventilated COVID‐19 patients at a high‐volume center in Bronx, NY The Laryngoscope 20211316E1797 80410.1002/lary.2939133410517Search in Google Scholar

23Bayrak V, Durukan NŞ, Aydemir FD, et al. Risk factors associated with mortality in ıntensive care COVID-19 patients: the importance of chest CT score and intubation timing as risk factors. Turkish journal of medical sciences. 2021;51(4):1665-74. Bayrak V Durukan NŞ Aydemir FD et al Risk factors associated with mortality in ıntensive care COVID-19 patients: the importance of chest CT score and intubation timing as risk factors Turkish journal of medical sciences 20215141665 7410.3906/sag-2101-89857633633957728Search in Google Scholar

24Lora-Tamayo J, Maestro G, Lalueza A, et al. Early Lopinavir/ ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. Journal of Infection. 2021;82(6):276-316. Lora-Tamayo J Maestro G Lalueza A et al Early Lopinavir/ ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study Journal of Infection 2021826276 31610.1016/j.jinf.2021.02.011787789233582204Search in Google Scholar